Americans age 60 and older lose more than $28 billion annually to financial exploitation, AARP estimated in 2023.
The Phase III study FIND-CKD (NCT05047263) — investigating the efficacy and safety of KERENDIA® (finerenone) versus placebo when added to standard of care in adult patients with non-diabetic chronic ...